APA (7th ed.) Citation

A, M., A, K., Y, A. M. M. E., O, K., Y, M., AA, R., . . . MA, A. (2020). FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. Pharmaceuticals (Basel, Switzerland), 13(12), . https://doi.org/10.3390/ph13120443

Chicago Style (17th ed.) Citation

A, Mostafa, et al. "FDA-Approved Drugs with Potent In Vitro Antiviral Activity Against Severe Acute Respiratory Syndrome Coronavirus 2." Pharmaceuticals (Basel, Switzerland) 13, no. 12 (2020). https://doi.org/10.3390/ph13120443.

MLA (9th ed.) Citation

A, Mostafa, et al. "FDA-Approved Drugs with Potent In Vitro Antiviral Activity Against Severe Acute Respiratory Syndrome Coronavirus 2." Pharmaceuticals (Basel, Switzerland), vol. 13, no. 12, 2020, https://doi.org/10.3390/ph13120443.